vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold
July 26, 2024 16:05 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead...
Genetic Technologies Strategic Restructure Driving USA Sales Growth
July 26, 2024 08:00 ET
|
Genetic Technologies Ltd
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious...
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 25, 2024 11:15 ET
|
G1 Therapeutics
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business
Update on August 8, 2024
Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update
July 25, 2024 02:00 ET
|
Verona Pharma plc
LONDON and RALEIGH, N.C., July 25, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the second...
Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
July 24, 2024 08:30 ET
|
Scorpius Holdings, Inc.
DURHAM, N.C., July 24, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization...
BioCryst to Report Second Quarter 2024 Financial Results on August 5
July 22, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., July 22, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2024 financial results...
Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
July 18, 2024 08:30 ET
|
Scorpius Holdings, Inc.
DURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO),...
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
July 18, 2024 08:00 ET
|
Science 37, Inc.
Science 37 enrolls 65 patients per month for its sponsor's Phase 3 infectious disease clinical trial.
Scorpius Holdings Announces Reverse Stock Split
July 17, 2024 16:30 ET
|
Scorpius Holdings, Inc.
DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization...
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
July 17, 2024 07:00 ET
|
Fortrea Holdings Inc
DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter...